For instance, the loss-of-function of protein tyrosine phosphatase non-receptor type 2 (PTPN2) negatively regulates T-cell activation, increasing the risk of IBD [58] and CeD [59]. Here, PTPN2 is linked to cranioectodermal dysplasia.